ES2067725T3 - Alergenos modificados quimicamente y procedimiento para su preparacion. - Google Patents

Alergenos modificados quimicamente y procedimiento para su preparacion.

Info

Publication number
ES2067725T3
ES2067725T3 ES90830412T ES90830412T ES2067725T3 ES 2067725 T3 ES2067725 T3 ES 2067725T3 ES 90830412 T ES90830412 T ES 90830412T ES 90830412 T ES90830412 T ES 90830412T ES 2067725 T3 ES2067725 T3 ES 2067725T3
Authority
ES
Spain
Prior art keywords
chemically modified
groups
allergic
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90830412T
Other languages
English (en)
Inventor
Paolo Falagiani
Oreste Brenna
Giovanni Mistrello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Farmaceutico Lofarma Sas
Original Assignee
Laboratorio Farmaceutico Lofarma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Farmaceutico Lofarma Sas filed Critical Laboratorio Farmaceutico Lofarma Sas
Application granted granted Critical
Publication of ES2067725T3 publication Critical patent/ES2067725T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

INDUCTORES DE ALERGIA QUIMICAMENTE MODIFICADOS, CUYA ACTIVIDAD ALERGICA SE REDUCE CON RESPECTO A LA DE LOS MATERIALES ALERGICOS NATIVOS CORRESPONDIENTES, LOS CUALES SON CAPACES DE INDUCIR ANTICUERPOS ESPECIFICOS DIRIGIDOS A DICHO MATERIAL ALERGICO NATIVO, EN DONDE UNA PARTE DE LOS GRUPOS AMINO PRIMARIOS DE LA MOLECULA DE PROTEINA DEL I. ALERGICO NATIVO SE MODIFICAN QUIMICAMENTE DE MODO QUE DAN GRUPOS AMINO CARBAMILICOS SUSTITUIDOS O SIMPLES, O GRUPOS AMINO TIOCARBAMILICOS SUSTITUIDOS, O GRUPOS GUANIDINO POSIBLEMENTE SUSTITUIDOS, Y PROCESO PARA SU PRODUCCION. LOS I. ALERGICOS ASI MODIFICADOS NO ESTAN POLIMERIZADOS CON EL RESTO, SON SOLUBLES EN MEDIO ACUATICO, SON RESISTENTES A LA HIDROLISIS TRIPTICA Y MUESTRAN PARTICULARMENTE CAPACIDAD PARA SER ADMINISTRADOS EN TRATAMIENTOS DE HIPOSENSIBILIZACION TERAPEUTICA.
ES90830412T 1989-10-06 1990-09-19 Alergenos modificados quimicamente y procedimiento para su preparacion. Expired - Lifetime ES2067725T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04843189A IT1237475B (it) 1989-10-06 1989-10-06 Allergeni modificati chimicamente e procedimento per la loro preparazione

Publications (1)

Publication Number Publication Date
ES2067725T3 true ES2067725T3 (es) 1995-04-01

Family

ID=11266497

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90830412T Expired - Lifetime ES2067725T3 (es) 1989-10-06 1990-09-19 Alergenos modificados quimicamente y procedimiento para su preparacion.

Country Status (11)

Country Link
US (1) US5354848A (es)
EP (1) EP0421949B1 (es)
JP (1) JPH0764874B2 (es)
AT (1) ATE114477T1 (es)
AU (1) AU637404B2 (es)
CA (1) CA2026610C (es)
DE (1) DE69014541T2 (es)
DK (1) DK0421949T3 (es)
ES (1) ES2067725T3 (es)
HK (1) HK1003979A1 (es)
IT (1) IT1237475B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566386B2 (en) 1993-08-09 2003-05-20 Nippon Zoki Pharmaceutical Co., Ltd. Immunomodulating and antiinflammatory agent
JP3193205B2 (ja) * 1993-08-09 2001-07-30 日本臓器製薬株式会社 好酸球増多抑制剤
JPH0959180A (ja) 1995-08-11 1997-03-04 Nippon Zoki Pharmaceut Co Ltd 活性化免疫グロブリン
JPH10212246A (ja) 1997-01-30 1998-08-11 Nippon Zoki Pharmaceut Co Ltd 経口投与用製剤
JP2000143536A (ja) 1998-11-13 2000-05-23 Nippon Zoki Pharmaceut Co Ltd 抗浮腫剤
US7142552B2 (en) * 2002-04-08 2006-11-28 International Business Machines Corporation Method and system for priority enforcement with flow control
WO2006097120A1 (en) * 2005-03-15 2006-09-21 Tred Srl A process for the preparation of hypoallergenic alimentary proteins
EP2140880B1 (en) 2008-07-04 2012-11-14 HAL Allergy Holding B.V. Modification of allergens
IT1391559B1 (it) * 2008-09-01 2012-01-11 Lofarma Spa Allergoidi derivati da allergeni
EP2239569A1 (en) 2009-04-09 2010-10-13 Lophius Biosciences GmbH Method for polypeptide transfer into cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3893993A (en) * 1969-08-06 1975-07-08 Beecham Group Ltd Allergenic extracts cross linked under acid conditions with inorganic cyanates
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation
US3761585A (en) * 1971-04-05 1973-09-25 Beecham Group Ltd Vaccines containing modified allergenic material
US4222907A (en) * 1978-09-25 1980-09-16 Scripps Clinic & Research Foundation Induction of immunological tolerance
US4234569A (en) * 1978-10-04 1980-11-18 The Johns Hopkins University Production of aldehyde-treated allergen-containing substances
US4469677A (en) * 1980-02-19 1984-09-04 Michael J Gabriel Polypeptide active immunosuppressant fraction
US4629706A (en) * 1982-02-01 1986-12-16 Miles Laboratories, Inc. Method for determining allergic sensitivity

Also Published As

Publication number Publication date
IT1237475B (it) 1993-06-07
EP0421949A1 (en) 1991-04-10
CA2026610C (en) 2000-01-04
ATE114477T1 (de) 1994-12-15
DE69014541T2 (de) 1995-06-22
HK1003979A1 (en) 1998-11-13
IT8948431A0 (it) 1989-10-06
CA2026610A1 (en) 1991-04-07
US5354848A (en) 1994-10-11
EP0421949B1 (en) 1994-11-30
DK0421949T3 (da) 1995-05-08
AU6315590A (en) 1991-04-11
JPH0764874B2 (ja) 1995-07-12
DE69014541D1 (de) 1995-01-12
JPH03151400A (ja) 1991-06-27
AU637404B2 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
ES2067725T3 (es) Alergenos modificados quimicamente y procedimiento para su preparacion.
DE69111179D1 (de) Amphoteres hydrogel für medizinische gegenstände.
BR8303968A (pt) Sutura composta e processo para sua preparacao
DE68926051D1 (de) Polypeptid-polymer-konjugate mit wundheilender wirkung
ATE131063T1 (de) Behandlung von fettleibigkeit mit einem alpha-2- adrenergen-agonisten und einem wachstumshormon freigebenden peptid.
Lubahn et al. Fasciectomy and Dupuytren's disease: a comparison between the open-palm technique and wound closure
RU94046025A (ru) Устройство для растягивания живой ткани
DE3880766D1 (de) Konjugate von interferon alpha mit immunglobulinen.
ES2186693T3 (es) Uso combinado del acido hialuronico y de agentes terapeuticos para mejorar el efecto terapeutico.
ES2119759T3 (es) Material de recubrimiento elastomero y guante fabricado con el mismo.
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
DE59006842D1 (de) Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung.
ATE97316T1 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
DK0621775T3 (da) Peptidlægemiddelholdige pellets, deres fremstilling og anvendelse.
FI894519A0 (fi) Pressningsanordning foer foerening av ihaoliga organ.
DE68905342D1 (de) Verwendung von minoxidil zur wundheilung.
Kucharzewski et al. Topical treatment of non-healing venous leg ulcers by cellulose membrane
FI893681A0 (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ES2025107B3 (es) Vendaje para el tratamiento de dolencias en el antebrazo
ATE168115T1 (de) In lösung bringen von proteinen in aktiver form
PT651654E (pt) Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa
Cox et al. Outpatient skin grafting of extremity burn wounds with the use of Unna Boot compression dressings
ES2086526T3 (es) Aplicacion medicinal de m-csf.
ES2168772T3 (es) Uso de hormona del crecimiento en composiciones para el tratamiento de la resistencia del corazon a la insulina.
ATE203680T1 (de) Konjugat zur behandlung von entzündungserkrankungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 421949

Country of ref document: ES